🔎 Trials Near Me

Akèy › Limfòm folikilè › New Jersey › Edison

Etid klinik pou Limfòm folikilè nan Edison, NJ

11 etid pou Limfòm folikilè ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Ap rekriteFaz 3
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07215910

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Ap rekriteFaz 3
  • Research Site, New Brunswick · 3 mi lwen
Laj 18 a 130 · Tout sèks · Mizajou Sep 21, 2026 · NCT06549595

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • Rutgers Cancer Institute, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

Ap rekriteFaz 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT04792502

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Ap rekriteFaz 2
  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT05389293

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Ap rekriteFaz 1
  • START New Jersey, East Brunswick · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07424833

SynKIR-310 for Relapsed/Refractory B-NHL

Ap rekriteFaz 1
  • Rutgers Cancer Institute, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06544265

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

Ap rekriteFaz 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 23, 2026 · NCT04998669

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Ap rekriteFaz 3
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT07029217

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, New Brunswick · 3 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Limfòm folikilè nan lòt vil

Lòt etid nan Edison

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.